- Home
- AQST vs BFST Comparison
AQST vs BFST Comparison
Compare AQST & BFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- BFST
- Stock Information
- Founded
- AQST 2004
- BFST 2006
- Country
- AQST United States
- BFST United States
- Employees
- AQST N/A
- BFST N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- BFST Major Banks
- Sector
- AQST Health Care
- BFST Finance
- Exchange
- AQST Nasdaq
- BFST Nasdaq
- Market Cap
- AQST 809.3M
- BFST 739.5M
- IPO Year
- AQST 2018
- BFST 2018
- Fundamental
- Price
- AQST $5.59
- BFST $25.05
- Analyst Decision
- AQST Strong Buy
- BFST Strong Buy
- Analyst Count
- AQST 7
- BFST 3
- Target Price
- AQST $10.00
- BFST $30.00
- AVG Volume (30 Days)
- AQST 3.0M
- BFST 107.3K
- Earning Date
- AQST 11-05-2025
- BFST 10-23-2025
- Dividend Yield
- AQST N/A
- BFST 2.43%
- EPS Growth
- AQST N/A
- BFST 11.95
- EPS
- AQST N/A
- BFST 2.60
- Revenue
- AQST $43,397,000.00
- BFST $303,637,000.00
- Revenue This Year
- AQST N/A
- BFST $24.29
- Revenue Next Year
- AQST $51.39
- BFST $17.04
- P/E Ratio
- AQST N/A
- BFST $9.49
- Revenue Growth
- AQST N/A
- BFST 21.51
- 52 Week Low
- AQST $2.12
- BFST $20.07
- 52 Week High
- AQST $7.55
- BFST $30.30
- Technical
- Relative Strength Index (RSI)
- AQST 37.83
- BFST 61.07
- Support Level
- AQST $5.44
- BFST $24.56
- Resistance Level
- AQST $6.85
- BFST $25.15
- Average True Range (ATR)
- AQST 0.42
- BFST 0.65
- MACD
- AQST -0.20
- BFST 0.11
- Stochastic Oscillator
- AQST 7.47
- BFST 75.91
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About BFST Business First Bancshares Inc.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.